Argyle Capital Management Inc. Merck & Co., Inc. Transaction History
Argyle Capital Management Inc.
- $271 Million
- Q2 2025
A detailed history of Argyle Capital Management Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Argyle Capital Management Inc. holds 59,301 shares of MRK stock, worth $4.78 Million. This represents 1.73% of its overall portfolio holdings.
Number of Shares
59,301
Previous 59,601
0.5%
Holding current value
$4.78 Million
Previous $5.35 Million
12.25%
% of portfolio
1.73%
Previous 2.02%
Shares
30 transactions
Others Institutions Holding MRK
# of Institutions
3,858Shares Held
1.92BCall Options Held
25.7MPut Options Held
24.2M-
Vanguard Group Inc Valley Forge, PA253MShares$20.4 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY207MShares$16.7 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$9.73 Billion0.46% of portfolio
-
Wellington Management Group LLP Boston, MA81.7MShares$6.59 Billion1.46% of portfolio
-
Geode Capital Management, LLC Boston, MA59MShares$4.76 Billion0.34% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $204B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...